USPTO serial 77934313
LEXURA
Reviewed by CopyMark Law Group
Reg. 3869567Status 713
- Filing date
- Status date
- Registration date
- Nov 2, 2010
- Examiner
- POLZER, NATALIE M
- Law office
- TTAB
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LEXURA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Frankfurt am Main, DE
Frankfurt am Main, DE
Frankfurt am Main, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey H. Kaufman
JEFFREY H KAUFMAN OBLON SPIVAK MCCLELLAND ET AL1940 DUKE STALEXANDRIA, VA 22314-3451UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations used for the treatment of cancer, pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer, pharmaceutical preparations used for the treatment of urological diseases, pharmaceutical preparations used for the treatment of hormonal disorders, peptides-containing pharmaceutical preparations used for hormonal and tumors treatments, pharmaceutical preparations used for the treatment of endocrine diseases, pharmaceutical preparations used for the treatment of carcinoid tumors, pharmaceutical preparations used for the treatment of age-related diseases, pharmaceutical preparation used for the treatment of endometriosis, pharmaceutical preparations used for the treatment of uterine myoma, pharmaceutical preparations used for the treatment of non-malignant tumors, pharmaceutical preparation used for the treatment for begnin prostatic hyperplasia BPH, pharmaceutical preparations used as a tubulin inhibitor, pharmaceutical preparations based on LHRH antagonists platform, pharmaceutical preparations based on angiogenesis inhibitors platform, pharmaceutical preparations used to induce apoptosis | SECTION 18 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2014 | C18. | CANCELLED SECTION 18-TOTAL | — |
| Aug 4, 2014 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Jul 27, 2014 | CANG | CANCELLATION GRANTED NO. 999999 | — |
| Dec 19, 2013 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| Nov 2, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 29, 2010 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Sep 28, 2010 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 25, 2010 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Sep 25, 2010 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Sep 7, 2010 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 13, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 13, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 5, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 5, 2010 | ALIE | ASSIGNED TO LIE | — |
| May 21, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 21, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 21, 2010 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 21, 2010 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 21, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 17, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| May 3, 2010 | PAPER RECEIVED | — | |
| Mar 17, 2010 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Mar 17, 2010 | ALIE | ASSIGNED TO LIE | — |
| Mar 3, 2010 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 18, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 16, 2010 | NWAP | NEW APPLICATION ENTERED | — |